The developed XAI framework, together with the pathogen-specific predictive models, the pathogen-selective fragment lists, and their mapping onto the chemical structures, is able to provide a highly valuable and practical guide to the rational design of new antimicrobial agents.
Abstract
The rise and extent of antimicrobial resistance demand computational tools that go beyond simple predictions of antimicrobial activity to deliver applicable medicinal chemistry insights for an accelerated and more efficient development of novel antimicrobials. Here, we present a fragment-based explainable artificial intelligence (XAI) framework, based on Relational Graph Convolutional Network (R-GCN) models trained with over 127,000 compounds from the Community for Open Antimicrobial Drug Discovery (CO-ADD) database and ChEMBL, targeting Staphylococcus aureus (Gram-positive), Escherichia coli (Gram-negative), and Candida albicans (fungal). External validation on 100,000 high-throughput screening compounds from the European Chemical Biology Database (ECBD) demonstrated the predictive performance of the three models and their utility in selecting compounds from a structurally divergent library, with enrichment factors up to 19-fold. Using substructure mask explanation (SME), we further decompose each prediction into fragment-based contribution scores and map them onto the chemical structures, allowing medicinal chemists to identify which scaffolds and substituents have a positive or negative effect on the activity against specific pathogens. From correctly predicted compounds, we further extracted pathogen-selective XAI fragments representing the core scaffolds responsible for activity, allowing a comparative analysis of these selective fragments between the different microbial classes and providing an evaluation tool for the antimicrobial potential of novel compound libraries. The developed XAI framework, together with the pathogen-specific predictive models, the pathogen-selective fragment lists, and their mapping onto the chemical structures, is able to provide a highly valuable and practical guide to the rational design of new antimicrobial agents.
This study provides an experimental assessment of model-guided AMP discovery and a reproducible route from computational prediction to validated antimicrobial candidates, while revealing biases and generalizability limits of AI-based AMP inference.
S. Ojeda, P. Ávila, S. Castellanos et al.· bioRxiv· 0 citations
An explainable machine-learning framework was developed to predict antibacterial activity of natural products using data from the NPASS 3.0 database and showed the highest overall contributions, while LogP was the most influential conventional molecular descriptor.
Deepthi Goteti· Natural Resources for Human...· 0 citations
The rapid emergence of global antimicrobial resistance (AMR) has outpaced the development of new antimicrobial agents, necessitating transformative approaches such as AI-driven in-silico drug discovery. Antimicrobial peptides (AMPs) are promising alternatives due to their broad-spectrum bactericidal activity and limite...
Naveed Saleem, E. El-Omar, Naresh Kumar et al.· Frontiers in Cellular and In...· 0 citations
With activity against multidrug-resistant pathogens and mechanisms distinct from conventional antibiotics, antimicrobial peptides (AMPs) offer a promising approach to combating antibiotic-resistant infections. However, their potency varies substantially across pathogen species, making accurate prediction of the minimum...
Experimental results demonstrate that PPsAMP significantly outperforms state-of-the-art models for identifying sAMPs, and has identified 14,839 candidate sAMPs from environmental metagenomes, most of which have not been previously reported.
Sheng-Xi Liu, Xi-Zhe Gao, Jing-Yu Wang et al.· Journal of Chemical Informat...· 0 citations
Related blog posts
MIT News · Artificial Intelligence· news.mit.eduNov 20, 2026
An MIT and Dana-Farber Institute-led team used large language models to examine nearly 4,000 studies and hundreds of code repositories, revealing gaps in the information needed to scrutinize and reuse published research.